Novadaq Technologies (NVDQ) 9.47 $NVDQ
NOVADAQ to Participate in June Investor Conferences
GlobeNewswire - Thu May 26, 3:30PM CDT
NOVADAQ Technologies Inc. ("NOVADAQ" or the "Company"
(NASDAQ:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, announced today that management will participate in three investor conferences in June.
NDQ.TO: 12.09 (-0.08), NVDQ: 9.47 (+0.04)
NOVADAQ Reports Voting Results From Annual Meeting of Shareholders
GlobeNewswire - Fri May 20, 12:45PM CDT
NOVADAQ(R) Technologies Inc. ("NOVADAQ" or the "Company" (NASDAQ:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant imaging solutions for use in surgical and diagnostic procedures, announced that at the annual meeting (the "Meeting" of shareholders of the Company (the "Shareholders" that was held on May 18, 2016, all seven (7) nominees for the board of directors were elected, the voting results of which are as follows:
NDQ.TO: 12.09 (-0.08), NVDQ: 9.47 (+0.04)
NOVADAQ to Participate in May Investor Conferences
GlobeNewswire - Fri Apr 29, 7:00AM CDT
NOVADAQ Technologies Inc. ("NOVADAQ" or the "Company" (NASDAQ:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, announced today that management will participate in three investor conferences in May.
NDQ.TO: 12.09 (-0.08), NVDQ: 9.47 (+0.04)
Novadaq reports 1Q loss
Automated Insights - Wed Apr 27, 6:27PM CDT
MISSISSAUGA, Ontario (AP) _ Novadaq Technologies Inc. (NVDQ) on Wednesday reported a loss of $7 million in its first quarter.
NDQ.TO: 12.09 (-0.08), NVDQ: 9.47 (+0.04)
NOVADAQ Reports First Quarter 2016 Financial Results
GlobeNewswire - Wed Apr 27, 3:03PM CDT
NOVADAQ Technologies Inc. ("NOVADAQ" or the "Company" (NASDAQ:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, today announced financial results for its first quarter ended March 31, 2016. Unless otherwise indicated, all dollar amounts in this press release are expressed in United States ("U.S." dollars.
NDQ.TO: 12.09 (-0.08), NVDQ: 9.47 (+0.04)
Investor Calendar Invites You to the NOVADAQ First Quarter 2016 Earnings Conference Call and Webcast Live on Wednesday, April 27, 2016
ACCESSWIRE - Tue Apr 26, 3:10PM CDT
TORONTO, ON / ACCESSWIRE / April 26, 2016 / NOVADAQ Technologies Inc. (NASDAQ: NVDQ) (TSX: NDQ) will host a conference call and live webcast to discuss the results of the first quarter 2016, to be held Wednesday, April 27, 2016 at 4:30 PM Eastern Time.
NDQ.TO: 12.09 (-0.08), NVDQ: 9.47 (+0.04)
NOVADAQ to Release First Quarter 2016 Financial Results on April 27, 2016 - Conference Call to Follow
GlobeNewswire - Mon Apr 11, 3:30PM CDT
NOVADAQ Technologies Inc. ("NOVADAQ" or the "Company" (NASDAQ:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, will announce financial results for the first quarter of 2016 after market close on Wednesday, April 27, 2016.
NDQ.TO: 12.09 (-0.08), NVDQ: 9.47 (+0.04)
NOVADAQ to Participate in the 15th Annual Needham Healthcare Conference
GlobeNewswire - Thu Mar 31, 7:30AM CDT
NOVADAQ Technologies Inc. ("NOVADAQ" or the "Company" (NASDAQ:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, announced today that management will present an update on the Company's business at the 15th Annual Needham Healthcare Conference on Tuesday, April 12, 2016 at 12:50 p.m. Eastern Time at the Westin Grand Central Hotel in New York, NY.
NDQ.TO: 12.09 (-0.08), NVDQ: 9.47 (+0.04)
NOVADAQ to Participate in the RBC Capital Markets 2016 Global Healthcare Conference
GlobeNewswire - Tue Feb 09, 3:30PM CST
Novadaq Technologies Inc. ("NOVADAQ" or the "Company" (NASDAQ:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, announced today that management will participate in a fireside chat presentation at the RBC Capital Markets 2016 Global Healthcare Conference on Tuesday, February 23, 2016 at 11:30 a.m. Eastern Time at the Palace Hotel in New York, NY.
NDQ.TO: 12.09 (-0.08), NVDQ: 9.47 (+0.04)
NOVADAQ Announces Fourth Quarter 2015 Preliminary Unaudited Revenues and Issues 2016 Revenue Guidance
GlobeNewswire - Mon Jan 11, 3:30PM CST
Novadaq Technologies Inc. ("NOVADAQ" or the "Company" (NASDAQ:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, announced today preliminary unaudited revenue for the fourth quarter of 2015 and provided 2016 revenue guidance ahead of its participation at the 34th Annual J.P. Morgan Healthcare Conference in San Francisco, CA.
JPM: 63.71 (+1.00), NDQ.TO: 12.09 (-0.08), NVDQ: 9.47 (+0.04)
Endoscopy Visualization Systems - Medical Devices Pipeline Assessment 2015 - Product Description, Licensing and Collaboration Details and Other Developmental Activities
M2 - Mon Dec 14, 8:44AM CST
Research and Markets (http://www.researchandmarkets.com/research/r9xlnb/endoscopy) has announced the addition of the "Endoscopy Visualization Systems - Medical Devices Pipeline Assessment, 2015" report to their offering. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Endoscopy Visualization Systems pipeline products. Scope - Extensive coverage of the Endoscopy Visualization Systems under development - The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities - The report reviews the major players involved in the development of Endoscopy Visualization Systems and list all their pipeline projects - The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage - The report provides key clinical trial data of ongoing trials specific to pipeline products - Recent developments in the segment / industry Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Products under Development 4 Endoscopy Visualization Systems - Pipeline Products under Development by Companies 5 Endoscopy Visualization Systems Companies and Product Overview 6 Endoscopy Visualization Systems- Recent Developments 7 Appendix Companies Mentioned - Aequorea Vision Medical, Inc. - Boston Scientific Corporation - Endopix Ltd. - Flex Film Kinetics - Georgia Regents University - HiTES(High-definition Tiny-head Endoscope System) - Imperial College London - KARL STORZ Endoscopy-America, Inc. - Lumendi Ltd. - Massachusetts Institute of Technology - Minimally Invasive Devices, LLC - NanoLite Systems, Inc. - Novadaq Technologies Inc. - NovoGI LTD - Olympus Corporation - Olympus Medical Systems Corp. - Otsuka Medical Devices Co., Ltd. - Pathfinder Technologies - Spectral Molecular Imaging, Inc. - The Johns Hopkins University - University of California, Irvine - University of California, San Diego - University of Central Florida - VitalView - Weill Cornell Medical College For more information visit http://www.researchandmarkets.com/research/r9xlnb/endoscopy
BSX: 22.87 (+0.21), NVDQ: 9.47 (+0.04)
NOVADAQ to Present at the 34th Annual J.P. Morgan Healthcare Conference
GlobeNewswire - Thu Dec 10, 7:25AM CST
Novadaq Technologies Inc. ("NOVADAQ" or the "Company" (NASDAQ:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, today announced that management will present an update on the Company's business at the 34 Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2016 at 8:00 a.m. Pacific Time at the Westin St. Francis Hotel in San Francisco, CA.
JPM: 63.71 (+1.00), NDQ.TO: 12.09 (-0.08), NVDQ: 9.47 (+0.04)
NOVADAQ to Participate in the 27th Annual Piper Jaffray Healthcare Conference
GlobeNewswire - Wed Nov 18, 3:30PM CST
Novadaq Technologies Inc. ("NOVADAQ" or the "Company" (NASDAQ:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, today announced that management will participate in a fireside chat presentation at the 27 Annual Piper Jaffray Healthcare Conference on Wednesday, December 2, 2015 at 12:30 p.m. Eastern Time at the New York Palace Hotel.
NDQ.TO: 12.09 (-0.08), NVDQ: 9.47 (+0.04)
NOVADAQ to Participate in November Investor Events
GlobeNewswire - Mon Nov 02, 7:00AM CST
Novadaq Technologies Inc. ("NOVADAQ" or the "Company" (NASDAQ:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, today announced that management will participate in three investor conferences in November.
NDQ.TO: 12.09 (-0.08), NVDQ: 9.47 (+0.04)
Leading 200 Global Small/Mid Cap Medical Devices/Technology/Supplies Companies
M2 - Thu Oct 22, 3:05AM CDT
Research and Markets (http://www.researchandmarkets.com/research/s5zdn4/global_smallmid) has announced the addition of the "Global Small/Mid Cap Medical Devices/Technology/Supplies 200 " report to their offering. The newly launched report identifies 200 Small/Mid cap medical devices/technology/supplies companies globally and covers various aspects of these 200 companies including news, financial/non-financial information and stock market analysis. The health care sector is expanding as more individuals obtain health insurance yet the investment opportunities are shrinking in market cap. Expected government cuts to Medicare and Medicaid, the uncertainty of health care reform and looming patent expirations are weighing heavily on the outlook of the biggest companies in the sector - large-cap stocks. Stunning growth opportunities are found among mid-cap and small cap companies where one to three key products are driving performance. Their size makes them easier to follow and their above-average growth rates make them attractive acquisition targets in a consolidating industry. The median top line growth rate among large-cap companies is at 4%, while that in mid-cap companies is about 7% and that in all the small caps is more than 10%. When we look at a sample of the best in small-cap companies, we are looking at 40% growth. The primary reason large-cap companies don't have small-cap-type growth is that, over the last 20 years, the larger caps have acquired or developed devices in sectors that have been penetrated at significantly higher rates than newer sectors. Revenue growth and gross margin expansion are key factors to consider when valuing a medical device company and, especially, a small- to mid-cap medical device company. Highlights - Leading 200 Global Small/Mid Cap medical devices/technology/supplies companies covered - Provides detailed research methodology for deriving the leading 200 Small/Mid Cap companies - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances of Global Small/Mid Cap medical devices/technology/supplies companies - International presence of Global Small/Mid Cap medical devices/technology/supplies companies - Key R&D activities by Global Small/Mid Cap medical devices/technology/supplies companies Key Topics Covered: 1: Rankings of Global Small/Mid Cap Medical Devices/Technology/Supplies Companies 2: Stock Market Performance over 12 Months: Leading 25 Global Small/Mid Cap Medical Devices/Technology/Supplies Companies with Most Increases 3: Key News of Global Small/Mid Cap Medical Devices/Technology/Supplies Companies for Year 2014-15 4: Key Alliances of Global Small/Mid Cap Medical Devices/Technology/Supplies Companies 5: International Presence of Global Small/Mid Cap Medical Devices/Technology/Supplies Companies 6: Research and Development Activities by Global Small/Mid Cap Medical Devices/Technology/Supplies Companies 7: Mergers and Acquisitions of Global Small/Mid Cap Medical Devices/Technology/Supplies Companies Companies Mentioned - Partial List - AS One Corporation - Abcam Plc - Advanced Medical Solutions Group PLC - Agfa-Gevaert NV - Ambu A/S - Analogic Corp - Asia Optical Company Incorporated - Capitol Health Ltd - Cellectis SA - Coherent Incorporated - Conmed Corporation - Ebos Group Limited - Ginko International Co Ltd - Gooch & Housego PLC - Greatbatch, Inc. - Hartalega Holdings Bhd - Hogy Medical Company Limited - I - Sens Inc - Icu Medical, Inc. - Ilex Medical Limited - Jeol Limited - Natus Medical, Incorporation - Nolato AB - Novadaq Technologies Inc - Omnicell, Inc. - Sorin SpA - Sun Hing Vision Group Holdings Limited - Sunny Optical Technology (Group) Company Limited - Tamron Co Ltd - Tecan Group AG - Thai Optical Group Public Company Limited - Tornier NV - Value Added Technology Co., Limited. - Vitrolife AB - Wonik Company Limited For more information visit http://www.researchandmarkets.com/research/s5...l_smallmid
ALOG: 82.60 (+0.73), GB: 31.81 (+0.76), TRNX: 20.67 (+0.28), BABY: 35.91 (+0.25), CLLS: 28.22 (+0.40), COHR: 92.76 (+0.73), OMCL: 33.34 (+0.58), NVDQ: 9.47 (+0.04)
NOVADAQ to Release Third Quarter 2015 Financial Results on October 28, 2015 - Conference Call to Follow
GlobeNewswire - Wed Oct 14, 3:30PM CDT
Novadaq Technologies Inc. ("NOVADAQ" or the "Company" (NASDAQ:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, will announce financial results for the third quarter of 2015 after market close on Wednesday, October 28, 2015.
NDQ.TO: 12.09 (-0.08), NVDQ: 9.47 (+0.04)
NOVADAQ and Arthrex Announce Co-Marketing Agreement for PINPOINT Fluorescence Imaging and 4K Synergy Systems
GlobeNewswire - Thu Oct 01, 6:00AM CDT
Novadaq Technologies Inc. ("NOVADAQ" or the "Company" (NASDAQ:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, today announced that it has entered into a Co-Marketing Agreement (the "Agreement" with Arthrex, Inc. ("Arthrex" , a global medical device company and leader in orthopaedic medical device innovation.
NDQ.TO: 12.09 (-0.08), NVDQ: 9.47 (+0.04)
NOVADAQ Unveils SPY-Q Case Management Software at the SAWC Fall Symposium
GlobeNewswire - Mon Sep 28, 3:30PM CDT
Novadaq Technologies Inc. ("NOVADAQ" or the "Company" (NASDAQ:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, today announced the unveiling of SPY-Q Case Manager (SPY-QCM), at the Symposium on Advanced Wound Care ("SWAC" Fall 2015 meeting being held in Las Vegas, Nevada from September 26-28.
NDQ.TO: 12.09 (-0.08), NVDQ: 9.47 (+0.04)
NOVADAQ to Host Analyst & Investor Day on November 16, 2015
GlobeNewswire - Tue Sep 22, 3:30PM CDT
Novadaq(R) Technologies Inc. ("NOVADAQ" or the "Company" (Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, will host an Analyst & Investor Day on Monday, November 16, 2015. The event will be held at the Sofitel Hotel in New York, NY from 9:00 a.m. to approximately 12:00 p.m. Eastern Time.
NDQ.TO: 12.09 (-0.08), NVDQ: 9.47 (+0.04)
NOVADAQ to Participate in June Investor Conferences
GlobeNewswire - Thu May 26, 3:30PM CDT
NOVADAQ Technologies Inc. ("NOVADAQ" or the "Company"
(NASDAQ:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, announced today that management will participate in three investor conferences in June. NDQ.TO: 12.09 (-0.08), NVDQ: 9.47 (+0.04)
NOVADAQ Reports Voting Results From Annual Meeting of Shareholders
GlobeNewswire - Fri May 20, 12:45PM CDT
NOVADAQ(R) Technologies Inc. ("NOVADAQ" or the "Company"
(NASDAQ:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant imaging solutions for use in surgical and diagnostic procedures, announced that at the annual meeting (the "Meeting" of shareholders of the Company (the "Shareholders" that was held on May 18, 2016, all seven (7) nominees for the board of directors were elected, the voting results of which are as follows: NDQ.TO: 12.09 (-0.08), NVDQ: 9.47 (+0.04)
NOVADAQ to Participate in May Investor Conferences
GlobeNewswire - Fri Apr 29, 7:00AM CDT
NOVADAQ Technologies Inc. ("NOVADAQ" or the "Company"
(NASDAQ:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, announced today that management will participate in three investor conferences in May. NDQ.TO: 12.09 (-0.08), NVDQ: 9.47 (+0.04)
Novadaq reports 1Q loss
Automated Insights - Wed Apr 27, 6:27PM CDT
MISSISSAUGA, Ontario (AP) _ Novadaq Technologies Inc. (NVDQ) on Wednesday reported a loss of $7 million in its first quarter.
NDQ.TO: 12.09 (-0.08), NVDQ: 9.47 (+0.04)
NOVADAQ Reports First Quarter 2016 Financial Results
GlobeNewswire - Wed Apr 27, 3:03PM CDT
NOVADAQ Technologies Inc. ("NOVADAQ" or the "Company"
(NASDAQ:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, today announced financial results for its first quarter ended March 31, 2016. Unless otherwise indicated, all dollar amounts in this press release are expressed in United States ("U.S." dollars. NDQ.TO: 12.09 (-0.08), NVDQ: 9.47 (+0.04)
Investor Calendar Invites You to the NOVADAQ First Quarter 2016 Earnings Conference Call and Webcast Live on Wednesday, April 27, 2016
ACCESSWIRE - Tue Apr 26, 3:10PM CDT
TORONTO, ON / ACCESSWIRE / April 26, 2016 / NOVADAQ Technologies Inc. (NASDAQ: NVDQ) (TSX: NDQ) will host a conference call and live webcast to discuss the results of the first quarter 2016, to be held Wednesday, April 27, 2016 at 4:30 PM Eastern Time.
NDQ.TO: 12.09 (-0.08), NVDQ: 9.47 (+0.04)
NOVADAQ to Release First Quarter 2016 Financial Results on April 27, 2016 - Conference Call to Follow
GlobeNewswire - Mon Apr 11, 3:30PM CDT
NOVADAQ Technologies Inc. ("NOVADAQ" or the "Company"
(NASDAQ:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, will announce financial results for the first quarter of 2016 after market close on Wednesday, April 27, 2016. NDQ.TO: 12.09 (-0.08), NVDQ: 9.47 (+0.04)
NOVADAQ to Participate in the 15th Annual Needham Healthcare Conference
GlobeNewswire - Thu Mar 31, 7:30AM CDT
NOVADAQ Technologies Inc. ("NOVADAQ" or the "Company"
(NASDAQ:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, announced today that management will present an update on the Company's business at the 15th Annual Needham Healthcare Conference on Tuesday, April 12, 2016 at 12:50 p.m. Eastern Time at the Westin Grand Central Hotel in New York, NY. NDQ.TO: 12.09 (-0.08), NVDQ: 9.47 (+0.04)
NOVADAQ to Participate in the RBC Capital Markets 2016 Global Healthcare Conference
GlobeNewswire - Tue Feb 09, 3:30PM CST
Novadaq Technologies Inc. ("NOVADAQ" or the "Company"
(NASDAQ:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, announced today that management will participate in a fireside chat presentation at the RBC Capital Markets 2016 Global Healthcare Conference on Tuesday, February 23, 2016 at 11:30 a.m. Eastern Time at the Palace Hotel in New York, NY. NDQ.TO: 12.09 (-0.08), NVDQ: 9.47 (+0.04)
NOVADAQ Announces Fourth Quarter 2015 Preliminary Unaudited Revenues and Issues 2016 Revenue Guidance
GlobeNewswire - Mon Jan 11, 3:30PM CST
Novadaq Technologies Inc. ("NOVADAQ" or the "Company"
(NASDAQ:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, announced today preliminary unaudited revenue for the fourth quarter of 2015 and provided 2016 revenue guidance ahead of its participation at the 34th Annual J.P. Morgan Healthcare Conference in San Francisco, CA. JPM: 63.71 (+1.00), NDQ.TO: 12.09 (-0.08), NVDQ: 9.47 (+0.04)
Endoscopy Visualization Systems - Medical Devices Pipeline Assessment 2015 - Product Description, Licensing and Collaboration Details and Other Developmental Activities
M2 - Mon Dec 14, 8:44AM CST
Research and Markets (http://www.researchandmarkets.com/research/r9xlnb/endoscopy) has announced the addition of the "Endoscopy Visualization Systems - Medical Devices Pipeline Assessment, 2015" report to their offering. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Endoscopy Visualization Systems pipeline products. Scope - Extensive coverage of the Endoscopy Visualization Systems under development - The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities - The report reviews the major players involved in the development of Endoscopy Visualization Systems and list all their pipeline projects - The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage - The report provides key clinical trial data of ongoing trials specific to pipeline products - Recent developments in the segment / industry Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Products under Development 4 Endoscopy Visualization Systems - Pipeline Products under Development by Companies 5 Endoscopy Visualization Systems Companies and Product Overview 6 Endoscopy Visualization Systems- Recent Developments 7 Appendix Companies Mentioned - Aequorea Vision Medical, Inc. - Boston Scientific Corporation - Endopix Ltd. - Flex Film Kinetics - Georgia Regents University - HiTES(High-definition Tiny-head Endoscope System) - Imperial College London - KARL STORZ Endoscopy-America, Inc. - Lumendi Ltd. - Massachusetts Institute of Technology - Minimally Invasive Devices, LLC - NanoLite Systems, Inc. - Novadaq Technologies Inc. - NovoGI LTD - Olympus Corporation - Olympus Medical Systems Corp. - Otsuka Medical Devices Co., Ltd. - Pathfinder Technologies - Spectral Molecular Imaging, Inc. - The Johns Hopkins University - University of California, Irvine - University of California, San Diego - University of Central Florida - VitalView - Weill Cornell Medical College For more information visit http://www.researchandmarkets.com/research/r9xlnb/endoscopy
BSX: 22.87 (+0.21), NVDQ: 9.47 (+0.04)
NOVADAQ to Present at the 34th Annual J.P. Morgan Healthcare Conference
GlobeNewswire - Thu Dec 10, 7:25AM CST
Novadaq Technologies Inc. ("NOVADAQ" or the "Company"
(NASDAQ:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, today announced that management will present an update on the Company's business at the 34 Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2016 at 8:00 a.m. Pacific Time at the Westin St. Francis Hotel in San Francisco, CA. JPM: 63.71 (+1.00), NDQ.TO: 12.09 (-0.08), NVDQ: 9.47 (+0.04)
NOVADAQ to Participate in the 27th Annual Piper Jaffray Healthcare Conference
GlobeNewswire - Wed Nov 18, 3:30PM CST
Novadaq Technologies Inc. ("NOVADAQ" or the "Company"
(NASDAQ:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, today announced that management will participate in a fireside chat presentation at the 27 Annual Piper Jaffray Healthcare Conference on Wednesday, December 2, 2015 at 12:30 p.m. Eastern Time at the New York Palace Hotel. NDQ.TO: 12.09 (-0.08), NVDQ: 9.47 (+0.04)
NOVADAQ to Participate in November Investor Events
GlobeNewswire - Mon Nov 02, 7:00AM CST
Novadaq Technologies Inc. ("NOVADAQ" or the "Company"
(NASDAQ:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, today announced that management will participate in three investor conferences in November. NDQ.TO: 12.09 (-0.08), NVDQ: 9.47 (+0.04)
Leading 200 Global Small/Mid Cap Medical Devices/Technology/Supplies Companies
M2 - Thu Oct 22, 3:05AM CDT
Research and Markets (http://www.researchandmarkets.com/research/s5zdn4/global_smallmid) has announced the addition of the "Global Small/Mid Cap Medical Devices/Technology/Supplies 200 " report to their offering. The newly launched report identifies 200 Small/Mid cap medical devices/technology/supplies companies globally and covers various aspects of these 200 companies including news, financial/non-financial information and stock market analysis. The health care sector is expanding as more individuals obtain health insurance yet the investment opportunities are shrinking in market cap. Expected government cuts to Medicare and Medicaid, the uncertainty of health care reform and looming patent expirations are weighing heavily on the outlook of the biggest companies in the sector - large-cap stocks. Stunning growth opportunities are found among mid-cap and small cap companies where one to three key products are driving performance. Their size makes them easier to follow and their above-average growth rates make them attractive acquisition targets in a consolidating industry. The median top line growth rate among large-cap companies is at 4%, while that in mid-cap companies is about 7% and that in all the small caps is more than 10%. When we look at a sample of the best in small-cap companies, we are looking at 40% growth. The primary reason large-cap companies don't have small-cap-type growth is that, over the last 20 years, the larger caps have acquired or developed devices in sectors that have been penetrated at significantly higher rates than newer sectors. Revenue growth and gross margin expansion are key factors to consider when valuing a medical device company and, especially, a small- to mid-cap medical device company. Highlights - Leading 200 Global Small/Mid Cap medical devices/technology/supplies companies covered - Provides detailed research methodology for deriving the leading 200 Small/Mid Cap companies - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances of Global Small/Mid Cap medical devices/technology/supplies companies - International presence of Global Small/Mid Cap medical devices/technology/supplies companies - Key R&D activities by Global Small/Mid Cap medical devices/technology/supplies companies Key Topics Covered: 1: Rankings of Global Small/Mid Cap Medical Devices/Technology/Supplies Companies 2: Stock Market Performance over 12 Months: Leading 25 Global Small/Mid Cap Medical Devices/Technology/Supplies Companies with Most Increases 3: Key News of Global Small/Mid Cap Medical Devices/Technology/Supplies Companies for Year 2014-15 4: Key Alliances of Global Small/Mid Cap Medical Devices/Technology/Supplies Companies 5: International Presence of Global Small/Mid Cap Medical Devices/Technology/Supplies Companies 6: Research and Development Activities by Global Small/Mid Cap Medical Devices/Technology/Supplies Companies 7: Mergers and Acquisitions of Global Small/Mid Cap Medical Devices/Technology/Supplies Companies Companies Mentioned - Partial List - AS One Corporation - Abcam Plc - Advanced Medical Solutions Group PLC - Agfa-Gevaert NV - Ambu A/S - Analogic Corp - Asia Optical Company Incorporated - Capitol Health Ltd - Cellectis SA - Coherent Incorporated - Conmed Corporation - Ebos Group Limited - Ginko International Co Ltd - Gooch & Housego PLC - Greatbatch, Inc. - Hartalega Holdings Bhd - Hogy Medical Company Limited - I - Sens Inc - Icu Medical, Inc. - Ilex Medical Limited - Jeol Limited - Natus Medical, Incorporation - Nolato AB - Novadaq Technologies Inc - Omnicell, Inc. - Sorin SpA - Sun Hing Vision Group Holdings Limited - Sunny Optical Technology (Group) Company Limited - Tamron Co Ltd - Tecan Group AG - Thai Optical Group Public Company Limited - Tornier NV - Value Added Technology Co., Limited. - Vitrolife AB - Wonik Company Limited For more information visit http://www.researchandmarkets.com/research/s5...l_smallmid
ALOG: 82.60 (+0.73), GB: 31.81 (+0.76), TRNX: 20.67 (+0.28), BABY: 35.91 (+0.25), CLLS: 28.22 (+0.40), COHR: 92.76 (+0.73), OMCL: 33.34 (+0.58), NVDQ: 9.47 (+0.04)
NOVADAQ to Release Third Quarter 2015 Financial Results on October 28, 2015 - Conference Call to Follow
GlobeNewswire - Wed Oct 14, 3:30PM CDT
Novadaq Technologies Inc. ("NOVADAQ" or the "Company"
(NASDAQ:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, will announce financial results for the third quarter of 2015 after market close on Wednesday, October 28, 2015. NDQ.TO: 12.09 (-0.08), NVDQ: 9.47 (+0.04)
NOVADAQ and Arthrex Announce Co-Marketing Agreement for PINPOINT Fluorescence Imaging and 4K Synergy Systems
GlobeNewswire - Thu Oct 01, 6:00AM CDT
Novadaq Technologies Inc. ("NOVADAQ" or the "Company"
(NASDAQ:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, today announced that it has entered into a Co-Marketing Agreement (the "Agreement" with Arthrex, Inc. ("Arthrex" , a global medical device company and leader in orthopaedic medical device innovation. NDQ.TO: 12.09 (-0.08), NVDQ: 9.47 (+0.04)
NOVADAQ Unveils SPY-Q Case Management Software at the SAWC Fall Symposium
GlobeNewswire - Mon Sep 28, 3:30PM CDT
Novadaq Technologies Inc. ("NOVADAQ" or the "Company"
(NASDAQ:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, today announced the unveiling of SPY-Q Case Manager (SPY-QCM), at the Symposium on Advanced Wound Care ("SWAC" Fall 2015 meeting being held in Las Vegas, Nevada from September 26-28. NDQ.TO: 12.09 (-0.08), NVDQ: 9.47 (+0.04)
NOVADAQ to Host Analyst & Investor Day on November 16, 2015
GlobeNewswire - Tue Sep 22, 3:30PM CDT
Novadaq(R) Technologies Inc. ("NOVADAQ" or the "Company"
(Nasdaq:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, will host an Analyst & Investor Day on Monday, November 16, 2015. The event will be held at the Sofitel Hotel in New York, NY from 9:00 a.m. to approximately 12:00 p.m. Eastern Time. NDQ.TO: 12.09 (-0.08), NVDQ: 9.47 (+0.04)
